Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1103
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03002779 | A Study to Characterize the Absorption, Metabolism, and Excretion of 14C-JNJ-53718678 After a Single Oral Dose in Healthy Male Participants | ||
| NCT02365597 | An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer | ||
| NCT00099983 | Risperidone Treatment for Military Service Related Chronic Post Traumatic Stress Disorder | ||
| NCT05818683 | A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer | ||
| NCT01254773 | Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease | ||
| NCT03001310 | Gene Therapy for Achromatopsia (CNGB3) | ||
| NCT01238991 | Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease | ||
| NCT06470438 | A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma | ||
| NCT01486277 | A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma | ||
| NCT02625857 | Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate Cancer | ||
| NCT04821323 | A Study Exploring the Use of Challenge Agents in Healthy Volunteers - Intervention Specific Appendix | ||
| NCT03829579 | Pre-Approval Access to Esketamine Nasal Spray for the Treatment of Treatment-Resistant Depression (TRD) | ||
| NCT04060888 | A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus | ||
| NCT03802682 | A Study of Apalutamide Administered Orally as Whole Tablets and as a Mixture in Applesauce in Healthy Participants | ||
| NCT03270579 | A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]JNJ-64511070 | ||
| NCT04583280 | A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV) | ||
| NCT04150887 | Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia | ||
| NCT05378906 | A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Compared to the Co-administration of the Separate Available Formulations of Darunavir and Cobicistat Under Fed Conditions in Healthy Participants | ||
| NCT04899336 | A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years | ||
| NCT00575055 | Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) | ||
| NCT00397033 | Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder. | ||
| NCT02659098 | A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy | ||
| NCT02497287 | A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression | ||
| NCT02505217 | Novel Biomarkers of Thrombotic Risk | ||
| NCT01051531 | A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia | ||
| NCT05299931 | An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients with Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study | ||
| NCT05441501 | A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer | ||
| NCT04673357 | A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease | ||
| NCT05754957 | A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome | ||
| NCT05845671 | Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations | ||
| NCT04132557 | A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine | ||
| NCT04919512 | A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder | ||
| NCT02299700 | Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder | ||
| NCT04312672 | Long-term Follow-up Gene Therapy Study for RPGR- XLRP | ||
| NCT03109002 | An Epidemiology Study of Treatment Resistant Depression in the United States (US) | ||
| NCT03399799 | Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT00210665 | A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment | ||
| NCT01846611 | A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | ||
| NCT02155192 | An Exploratory Genetic Study in Participants With Psoriasis | ||
| NCT02877134 | Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease | ||
| NCT01813539 | A Study of ARGX-110 in Participants With Advanced Malignancies | ||
| NCT02638116 | A Drug Interaction Study to Assess the Effect of Omeprazole on the Pharmacokinetics of Ibrutinib in Healthy Adults | ||
| NCT02313909 | Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS) | ||
| NCT01674647 | Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion | ||
| NCT01284387 | Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease | ||
| NCT03767244 | A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy | ||
| NCT03007693 | A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ 61393215 in Healthy Participants | ||
| NCT05197049 | A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease | ||
| NCT01966549 | A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease | ||
| NCT06348108 | Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma |
